A cost-effectiveness analysis of three treatments for age-related macular degeneration

Retina
Emily W GowerNeil M Bressler

Abstract

The purpose of this study was to evaluate the cost effectiveness of pegaptanib sodium and ranibizumab injections compared with photodynamic therapy (PDT) with verteporfin for the treatment of choroidal neovascularization secondary to age-related macular degeneration. The analyses were performed using outcomes data from the pivotal trials for each treatment and the medicare reimbursable costs for each treatment and associated medical procedures. A multistate transition model with 3-month cycles was created to compare incremental medical costs associated with pegaptanib or ranibizumab versus PDT for patients with starting vision of 20/40, 20/80, and 20/200 Snellen equivalent. Two-year medical treatment costs ranged from $3,100 to $54,100 depending on treatment and lesion type. Photodynamic therapy was less costly and more effective than pegaptanib for predominantly classic and minimally classic lesions. Ranibizumab was not only more effective but also more costly than PDT for all lesion types. Compared with PDT, pegaptanib is inferior in both cost and effectiveness, whereas ranibizumab has a greater effectiveness. Because ranibizumab does not meet 1 of the common thresholds for being considered cost effective (<$50,000 per qualit...Continue Reading

References

Jan 1, 1989·Journal of Clinical Epidemiology·D G Froberg, R L Kane
Jan 1, 1989·Journal of Clinical Epidemiology·D G Froberg, R L Kane
Jan 1, 1989·Journal of Clinical Epidemiology·D G Froberg, R L Kane
Jan 1, 1989·Journal of Clinical Epidemiology·D G Froberg, R L Kane
Nov 1, 1996·Journal of American College Health : J of ACH·D MillsM Curran
Sep 1, 1996·Nature Biotechnology·L Gold
Nov 21, 2002·Archives of Ophthalmology·Neil M BresslerUNKNOWN Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group
Feb 14, 2003·Archives of Ophthalmology·Traci E ClemonsUNKNOWN Age-Related Eye Disease Study Research Group
Apr 11, 2003·Survey of Ophthalmology·Melissa M BrownJennifer Landy
Apr 3, 2004·American Journal of Ophthalmology·Jennifer J ArnoldUNKNOWN Verteporfin in Photodynamic Therapy Study Group
Apr 14, 2004·Archives of Ophthalmology·Nathan CongdonUNKNOWN Eye Diseases Prevalence Research Group
Dec 4, 2004·International Ophthalmology Clinics·Brandon G BusbeeMelissa M Brown
Dec 31, 2004·The New England Journal of Medicine·Evangelos S GragoudasUNKNOWN VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group
Apr 13, 2005·Archives of Ophthalmology·Mohammad AzabUNKNOWN Visudyne in Minimally Classic Choroidal Neovascularization Study Group
May 5, 2005·Current Opinion in Ophthalmology·Melissa M Brown, Gary C Brown
Jun 11, 2005·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Sanjay SharmaGaurav K Shah
May 2, 2006·Ophthalmology·UNKNOWN VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial GroupB Katz
Oct 6, 2006·The New England Journal of Medicine·Philip J RosenfeldUNKNOWN MARINA Study Group
Oct 6, 2006·The New England Journal of Medicine·David M BrownUNKNOWN ANCHOR Study Group
Jan 9, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jonathan C JavittAnthony P Adamis
Jun 25, 2008·Cost Effectiveness and Resource Allocation : C/E·Susan F HurleyRobyn H Guymer

❮ Previous
Next ❯

Citations

Jun 10, 2011·Clinical Ophthalmology·Giuseppe QuerquesEric H Souied
Nov 19, 2013·Journal of Comparative Effectiveness Research·Emily W Gower
Nov 14, 2015·PharmacoEconomics·Jordana K Schmier, Carolyn K Hulme-Lowe
Aug 17, 2011·American Journal of Ophthalmology·Shelley DayFrank A Sloan
Sep 18, 2016·Applied Health Economics and Health Policy·Thomas ButtGary Rubin
Feb 3, 2016·Molecular Pharmaceutics·Nickisa HodgsonJiawei Wang
Aug 30, 2014·The Cochrane Database of Systematic Reviews·Sharon D SolomonBarbara S Hawkins
Mar 6, 2019·The Cochrane Database of Systematic Reviews·Sharon D SolomonBarbara S Hawkins

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.